DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Cirak S, Arechavala-Gomeza V, Guglieri M , et al.
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.
Lancet 2011;
378 (9791) 595-605
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.